Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-β secretion via deregulated lysosomal exocytosis | Nature Communications
Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin α5β1 interaction and Akt signaling pathway | Cell Communication and Signaling | Full Text
An intrinsic mechanism of secreted protein aging and turnover
World J Oncol
Schematic representation demonstrating downstream of NEU1 deficiency... | Download Scientific Diagram
Datei:Begriffsklärung neu1.svg – Wikipedia
Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis | Oncotarget
Lipopolysaccharide activates microglia via neuraminidase 1 desialylation of Toll‐like Receptor 4 - Allendorf - 2020 - Journal of Neurochemistry - Wiley Online Library
Selective Inhibitors of Human Neuraminidase 1 (NEU1) | Journal of Medicinal Chemistry
Neu1 siRNA (h), shRNA and Lentiviral Particle Gene Silencers | SCBT - Santa Cruz Biotechnology
NEU1 structure analysis and localization of the 9 candidate missense... | Download Scientific Diagram
Figure 1.3 from Neu1 Sialidase and Matrix Metalloproteinase-9 Cross-talk Is Essential for Toll-like Receptor Activation and Cellular Signaling* | Semantic Scholar
Pathways showing NEU1 conversion of N-acetylneuraminic to acid... | Download Scientific Diagram
Neuraminidase 1 activates insulin receptor and reverses insulin resistance in obese mice - ScienceDirect
Therapeutic Potential of Neu1 in Alzheimer's Disease Via the Immune System - Aiza Khan, Sumit Das, Consolato Sergi, 2021
Frontiers | Modulation of TLR4 Sialylation Mediated by a Sialidase Neu1 and Impairment of Its Signaling in Leishmania donovani Infected Macrophages
Identification of CD36 as a new interaction partner of membrane NEU1: potential implication in the pro-atherogenic effects of the elastin receptor complex | SpringerLink
Frontiers | NEU1—A Unique Therapeutic Target for Alzheimer's Disease
Sialidase-1 (NEU1) Antibody | Abbexa Ltd
JCM | Free Full-Text | Conventional and Unconventional Therapeutic Strategies for Sialidosis Type I
Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis | Oncotarget
NEU1 antibody (67032-1-Ig) | Proteintech
Therapeutic Potential of Neu1 in Alzheimer's Disease Via the Immune System - Aiza Khan, Sumit Das, Consolato Sergi, 2021
Sialidase-1 - Wikipedia
